ADMA BIOLOGICS INC (ADMA)
NASDAQ • Healthcare
Last close at August 10, 2026 at 20:00 UTC
Fundamentals Charts
About ADMA BIOLOGICS INC
ADMA Biologics, Inc. (NASDAQ: ADMA) is a healthcare biotechnology company that develops, manufactures, and commercializes plasma-derived biologic therapies. Its business centers on immune globulin and hepatitis B products sold in the United States and abroad, and it generated $510.2 million of revenue in FY2025.
Analyst Ratings
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings Calendar
Technical Indicators
ADMA BIOLOGICS INC's Technical Indicators Summary
ADMA posts a Buy stance reflecting constructive short- and medium-term momentum against a backdrop of longer-term resistance and mixed volume. The price sits above the 10–50 period averages while remaining below the 200-day level, and momentum measures such as a mid-60s RSI, elevated CCI and a positive MACD support the near-term advance. ADX indicates only modest trend strength and ATR is moderate around 3.9%, while OBV shows on-balance buying despite a negative absolute reading. Technical takeaway: Buy.
| Indicator | Value |
|---|---|
RSI (14) | 64.84 |
Stochastic %K (14, 3, 3) | 79.60 |
CCI (20) | 181.54 |
WPR (14) | -27.40 |
Momentum (10) | 1.27 |
MFI | 59.48 |
MACD Level (12, 26) | 0.24 |
Bollinger Bands | $7.85 - $9.87 |
ATR (14) | $0.38 (3.89%) |
ADX (14) | 20.34 |
OBV | -102,505,951 |
Classic Pivot Point | $9.95 |
Fibonacci Pivot Point | $9.95 |
Simple Moving Averages | $8.64 - $13.18(5 indicators) |
Exponential Moving Averages | $9.03 - $12.50(5 indicators) |
Get premium market insights delivered directly to your inbox.
Today's Snapshot
The stock drifted slightly lower in the last session, ending at 9.75, a modest -1.52% move down. ADMA faces new securities-fraud lawsuits from Rosen Law Firm and SBS, heightening litigation risk.
Trading Volume
Below 10d avg (2.7M)
1.8M
vs S&P 500 Today
Underperforming Market
-1.46%
52-Week Position
Lower range
19.2%
Updated: August 11, 2026 at 12:04 UTC
Quote Summary
ADMA Headlines
Valuation Shifts In Major Healthcare Stocks
March 25, 2026